NextCure, Inc.
NXTC
$0.3348
$0.00210.63%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -20.24% | -22.06% | -21.95% | -12.82% | -9.23% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -15.42% | -13.04% | -13.07% | -8.14% | -10.90% |
| Operating Income | 15.42% | 13.04% | 13.07% | 8.14% | 10.90% |
| Income Before Tax | 11.27% | 10.74% | 12.67% | 9.25% | 16.07% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 11.27% | 10.74% | 12.67% | 9.25% | 16.07% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.27% | 10.74% | 12.67% | 9.25% | 16.07% |
| EBIT | 15.42% | 13.04% | 13.07% | 8.14% | 10.90% |
| EBITDA | 15.03% | 12.51% | 12.83% | 7.87% | 10.91% |
| EPS Basic | 11.66% | 11.15% | 13.05% | 9.60% | 16.35% |
| Normalized Basic EPS | 15.72% | 15.02% | 16.67% | 13.21% | 16.35% |
| EPS Diluted | 11.66% | 11.15% | 13.05% | 9.74% | 16.48% |
| Normalized Diluted EPS | 15.72% | 15.02% | 16.67% | 13.21% | 16.35% |
| Average Basic Shares Outstanding | 0.46% | 0.48% | 0.44% | 0.39% | 0.33% |
| Average Diluted Shares Outstanding | 0.46% | 0.48% | 0.44% | 0.39% | 0.33% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |